Altay Tekeş Shares Five-Year Review of AI in Cancer Research at ESMO 2026
Altay Tekeş/Linkedin

Altay Tekeş Shares Five-Year Review of AI in Cancer Research at ESMO 2026

Altay Tekeş, Medical Oncology Fellow at Gazi University, shared on LinkedIn:

“I’m happy to share our poster at the ESMO AI and Digital Oncology Congress 2026 in Berlin!

369P – Artificial intelligence content at the ESMO – European Society for Medical Oncology Congress 2021-2025: prevalence, application domains, validation level and geography.

We screened all 11,604 abstracts in the ESMO Congress abstract books over five years. AI was a substantive component in 491 (4.2%), rising from 2.0% in 2021 to 5.4% in 2025. Large language models first appeared in 2023 and made up 11.8% of AI abstracts in 2025. Yet only 32% of AI studies reported external, prospective or randomized validation, and just 2 were randomized trials.

Our message: AI research in oncology is growing fast, but validation and reporting need to catch up before it can reach the clinic.

I sincerely thank my mentor Fatih Gürler and my professors Ahmet Özet, Aytug Uner, Prof. Uğur Coşkun and Nuriye Özdemir for their continuous support, guidance, and encouragement. Thank you also to my colleagues İmdat Eroğlu and Ayşe Arslan Kapuci for their contributions to this work.

Many thanks to the congress co-chairs Jakob Nikolas Kather, Mireia Crispin and Rudolf Fehrmann for an excellent meeting, and for the opportunity to meet so many experts in the field in one place.”

You may also be interested in: